Matches in SemOpenAlex for { <https://semopenalex.org/work/W2589395295> ?p ?o ?g. }
- W2589395295 endingPage "2590" @default.
- W2589395295 startingPage "2573" @default.
- W2589395295 abstract "Glutaminyl cyclase (QC) has been implicated in the formation of toxic amyloid plaques by generating the N-terminal pyroglutamate of β-amyloid peptides (pGlu-Aβ) and thus may participate in the pathogenesis of Alzheimer's disease (AD). We designed a library of glutamyl cyclase (QC) inhibitors based on the proposed binding mode of the preferred substrate, Aβ3E-42. An in vitro structure-activity relationship study identified several excellent QC inhibitors demonstrating 5- to 40-fold increases in potency compared to a known QC inhibitor. When tested in mouse models of AD, compound 212 significantly reduced the brain concentrations of pyroform Aβ and total Aβ and restored cognitive functions. This potent Aβ-lowering effect was achieved by incorporating an additional binding region into our previously established pharmacophoric model, resulting in strong interactions with the carboxylate group of Glu327 in the QC binding site. Our study offers useful insights in designing novel QC inhibitors as a potential treatment option for AD." @default.
- W2589395295 created "2017-03-03" @default.
- W2589395295 creator A5000439028 @default.
- W2589395295 creator A5006581729 @default.
- W2589395295 creator A5011861620 @default.
- W2589395295 creator A5014705125 @default.
- W2589395295 creator A5018480071 @default.
- W2589395295 creator A5019606080 @default.
- W2589395295 creator A5035870764 @default.
- W2589395295 creator A5037660285 @default.
- W2589395295 creator A5049540107 @default.
- W2589395295 creator A5049621254 @default.
- W2589395295 creator A5061730458 @default.
- W2589395295 creator A5064176020 @default.
- W2589395295 creator A5077585796 @default.
- W2589395295 creator A5085377484 @default.
- W2589395295 creator A5091109862 @default.
- W2589395295 date "2017-03-13" @default.
- W2589395295 modified "2023-10-15" @default.
- W2589395295 title "Discovery of Potent Human Glutaminyl Cyclase Inhibitors as Anti-Alzheimer’s Agents Based on Rational Design" @default.
- W2589395295 cites W1463415903 @default.
- W2589395295 cites W1516427878 @default.
- W2589395295 cites W1552912270 @default.
- W2589395295 cites W1587774683 @default.
- W2589395295 cites W1607136952 @default.
- W2589395295 cites W1964747897 @default.
- W2589395295 cites W1974145718 @default.
- W2589395295 cites W1979109833 @default.
- W2589395295 cites W1990632702 @default.
- W2589395295 cites W1991988242 @default.
- W2589395295 cites W1993158184 @default.
- W2589395295 cites W1996840082 @default.
- W2589395295 cites W1997895427 @default.
- W2589395295 cites W1998169335 @default.
- W2589395295 cites W2009886346 @default.
- W2589395295 cites W2010357514 @default.
- W2589395295 cites W2010440072 @default.
- W2589395295 cites W2013785414 @default.
- W2589395295 cites W2027083068 @default.
- W2589395295 cites W2028578297 @default.
- W2589395295 cites W2044646578 @default.
- W2589395295 cites W2051559087 @default.
- W2589395295 cites W2052153647 @default.
- W2589395295 cites W2059214757 @default.
- W2589395295 cites W2067151302 @default.
- W2589395295 cites W2070071706 @default.
- W2589395295 cites W2071310220 @default.
- W2589395295 cites W2080705044 @default.
- W2589395295 cites W2083481304 @default.
- W2589395295 cites W2089013306 @default.
- W2589395295 cites W2089791279 @default.
- W2589395295 cites W2092588162 @default.
- W2589395295 cites W2095253097 @default.
- W2589395295 cites W2096410114 @default.
- W2589395295 cites W2108629610 @default.
- W2589395295 cites W2126690234 @default.
- W2589395295 cites W2138645148 @default.
- W2589395295 cites W2153767421 @default.
- W2589395295 cites W2154632236 @default.
- W2589395295 cites W2170644095 @default.
- W2589395295 cites W2192963340 @default.
- W2589395295 cites W2316873961 @default.
- W2589395295 cites W2413104535 @default.
- W2589395295 cites W2950757303 @default.
- W2589395295 doi "https://doi.org/10.1021/acs.jmedchem.7b00098" @default.
- W2589395295 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28234463" @default.
- W2589395295 hasPublicationYear "2017" @default.
- W2589395295 type Work @default.
- W2589395295 sameAs 2589395295 @default.
- W2589395295 citedByCount "32" @default.
- W2589395295 countsByYear W25893952952018 @default.
- W2589395295 countsByYear W25893952952019 @default.
- W2589395295 countsByYear W25893952952020 @default.
- W2589395295 countsByYear W25893952952021 @default.
- W2589395295 countsByYear W25893952952022 @default.
- W2589395295 countsByYear W25893952952023 @default.
- W2589395295 crossrefType "journal-article" @default.
- W2589395295 hasAuthorship W2589395295A5000439028 @default.
- W2589395295 hasAuthorship W2589395295A5006581729 @default.
- W2589395295 hasAuthorship W2589395295A5011861620 @default.
- W2589395295 hasAuthorship W2589395295A5014705125 @default.
- W2589395295 hasAuthorship W2589395295A5018480071 @default.
- W2589395295 hasAuthorship W2589395295A5019606080 @default.
- W2589395295 hasAuthorship W2589395295A5035870764 @default.
- W2589395295 hasAuthorship W2589395295A5037660285 @default.
- W2589395295 hasAuthorship W2589395295A5049540107 @default.
- W2589395295 hasAuthorship W2589395295A5049621254 @default.
- W2589395295 hasAuthorship W2589395295A5061730458 @default.
- W2589395295 hasAuthorship W2589395295A5064176020 @default.
- W2589395295 hasAuthorship W2589395295A5077585796 @default.
- W2589395295 hasAuthorship W2589395295A5085377484 @default.
- W2589395295 hasAuthorship W2589395295A5091109862 @default.
- W2589395295 hasConcept C107824862 @default.
- W2589395295 hasConcept C126322002 @default.
- W2589395295 hasConcept C171250308 @default.
- W2589395295 hasConcept C181199279 @default.
- W2589395295 hasConcept C185592680 @default.
- W2589395295 hasConcept C192562407 @default.